Human Health Holdings Limited (HKG:1419)
Hong Kong · Delayed Price · Currency is HKD 0.8200
-0.0300 (-3.53%)
Mar 9, 2026, 3:45 PM HKT
Human Health Holdings Income Statement
Financials in millions HKD. Fiscal year is July - June.
Millions HKD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
| 670.99 | 644.43 | 590.82 | 1,002 | 1,122 | 654.71 | |
Revenue Growth (YoY) | 9.74% | 9.07% | -41.02% | -10.70% | 71.34% | 44.29% |
Cost of Revenue | 364.79 | 348.97 | 320.97 | 408.51 | 462.11 | 278.02 |
Gross Profit | 306.21 | 295.46 | 269.85 | 593.24 | 659.69 | 376.69 |
Selling, General & Admin | 203.77 | 197.7 | 184.47 | 211.18 | 166.7 | 152.37 |
Amortization of Goodwill & Intangibles | 1.35 | 1.49 | 1.61 | 1.61 | 1.61 | 1.61 |
Operating Expenses | 271.5 | 265.17 | 251.7 | 286.16 | 230.88 | 230.63 |
Operating Income | 34.71 | 30.29 | 18.15 | 307.07 | 428.81 | 146.06 |
Interest Expense | -6.61 | -6.55 | -8.22 | -8.3 | -2.93 | -2.93 |
Interest & Investment Income | 8.19 | 12.7 | 16.61 | 8.49 | 0.2 | 0.29 |
Earnings From Equity Investments | 0.19 | -0.24 | -1.27 | -1.54 | -1.98 | 0.99 |
Other Non Operating Income (Expenses) | 1.5 | 1.96 | 1.88 | 2.51 | 0.82 | 0.14 |
EBT Excluding Unusual Items | 37.97 | 38.16 | 27.15 | 308.23 | 424.92 | 144.55 |
Gain (Loss) on Sale of Investments | 2.15 | 2.28 | 16.58 | -6.27 | 25.52 | 2.63 |
Asset Writedown | -7.6 | -10.5 | -17.16 | -63.15 | -10 | - |
Other Unusual Items | - | - | - | - | 4.82 | 21.63 |
Pretax Income | 32.53 | 29.94 | 26.56 | 238.82 | 445.26 | 168.82 |
Income Tax Expense | 3.82 | 3.31 | 2.38 | 57.98 | 69.95 | 24.37 |
Earnings From Continuing Operations | 28.71 | 26.63 | 24.19 | 180.84 | 375.31 | 144.45 |
Minority Interest in Earnings | -0.94 | -0.3 | - | - | - | - |
Net Income | 27.77 | 26.34 | 24.19 | 180.84 | 375.31 | 144.45 |
Net Income to Common | 27.77 | 26.34 | 24.19 | 180.84 | 375.31 | 144.45 |
Net Income Growth | 32.36% | 8.88% | -86.62% | -51.82% | 159.81% | - |
Shares Outstanding (Basic) | 380 | 380 | 380 | 380 | 380 | 380 |
Shares Outstanding (Diluted) | 380 | 380 | 380 | 380 | 380 | 380 |
EPS (Basic) | 0.07 | 0.07 | 0.06 | 0.48 | 0.99 | 0.38 |
EPS (Diluted) | 0.07 | 0.07 | 0.06 | 0.48 | 0.99 | 0.38 |
EPS Growth | 32.73% | 8.27% | -86.61% | -51.86% | 159.81% | - |
Free Cash Flow | - | 90.83 | -26.3 | 580.24 | 219.3 | 71.44 |
Free Cash Flow Per Share | - | 0.24 | -0.07 | 1.53 | 0.58 | 0.19 |
Dividend Per Share | - | 0.030 | 0.028 | 0.160 | 0.300 | 0.120 |
Dividend Growth | - | 7.14% | -82.50% | -46.67% | 150.00% | - |
Gross Margin | 45.63% | 45.85% | 45.67% | 59.22% | 58.81% | 57.54% |
Operating Margin | 5.17% | 4.70% | 3.07% | 30.65% | 38.22% | 22.31% |
Profit Margin | 4.14% | 4.09% | 4.09% | 18.05% | 33.46% | 22.06% |
Free Cash Flow Margin | - | 14.09% | -4.45% | 57.92% | 19.55% | 10.91% |
EBITDA | 32.38 | 50.62 | 39.07 | 323.46 | 437.63 | 155.85 |
EBITDA Margin | 4.83% | 7.85% | 6.61% | 32.29% | 39.01% | 23.80% |
D&A For EBITDA | -2.33 | 20.34 | 20.92 | 16.39 | 8.83 | 9.79 |
EBIT | 34.71 | 30.29 | 18.15 | 307.07 | 428.81 | 146.06 |
EBIT Margin | 5.17% | 4.70% | 3.07% | 30.65% | 38.22% | 22.31% |
Effective Tax Rate | 11.75% | 11.05% | 8.94% | 24.28% | 15.71% | 14.43% |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.